Edition:
United States

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

34.96USD
17 Aug 2018
Change (% chg)

$-0.56 (-1.58%)
Prev Close
$35.52
Open
$35.38
Day's High
$35.38
Day's Low
$33.76
Volume
37,617
Avg. Vol
65,519
52-wk High
$45.61
52-wk Low
$15.37

Chart for

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $1,316.50
Shares Outstanding(Mil.): 37.66
Dividend: --
Yield (%): --

Financials

  DCPH.OQ Industry Sector
P/E (TTM): -- 95.67 30.17
EPS (TTM): -2.35 -- --
ROI: -34.27 3.33 12.67
ROE: -86.28 2.31 14.86

Earnings vs. Estimates